Hide Board Information

Show Board Information

BioBlast Pharma Ltd. ORPN

Board Mod: Add me as mod

Asst Mods:

Last Post: 03/06/2019 1:11:40 PM

Board Marks: 1

Posts Today: 0

Board Views Today: 2

BioBlast Pharma Ltd. (Nasdaq: ORPN)

Company Website: http://bioblast-pharma.com/

BioBlast Pharma Ltd. (NASDAQ: ORPN) Stock Message Board

1. ORPN Company Profile

    

2. ORPN Time & Sales

    

3. ORPN Recent News

    

4. ORPN Filings

    

5. ORPN Financials

    

6. ORPN Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

6	$ORPN News Article - Bioblast Announces	whytestocks	03/06/2019 1:11:40 PM
5	28.97% v7,517,530 c1.5100 f3,359,109 gap up BO1.6	znewcar1	02/19/2019 4:29:20 PM
4	30.25% v2,791,319 c1.5500 f3,342,393 a cup kind	znewcar1	11/20/2018 4:11:25 PM
3	ORPN Stock is number 97 for the largest	danrocks	12/21/2015 6:14:13 PM
2	ORPN Stock is number 168 for the largest	danrocks	12/18/2015 11:13:00 PM
1	ORPN 4.36 Bio Blast Pharma Ltd $ORPN stock added	clayton	12/18/2015 10:01:35 PM

Recent Articles

• NewAmsterdam Pharma Secures $416.5 Million Offering for Growth
• STEP Energy Services Ltd. Unveils 2025 Budget and Updates
• Wondershare Filmora 14 Receives Apple ProRes Certification
• Rugby Resources Limited Expands Private Placement Offerings
• AmpliTech Group Unveils $2.2 Million Direct Offering Plan
• ServiceTitan Sets Price for Its Upcoming IPO Offering
• Teamsters Union Gains Over 1,000 Amazon Workers at KSBD Hub
• Menarini Group and MEDSIR Unveil New Breast Cancer Study Insights
• NIQ BASES Honors Pioneering Innovations Shaping Consumer Trends
• Kura Sushi Set to Showcase Global Flavors at Expo 2025
• WD-40 Company Boosts Dividend and Announces Earnings Call Details
• Emerging Trends in Impact Investing: Shaping a Sustainable Future
• Transformative Growth in Modular Energy Control Systems Market
• 8x8 and Descope Join Forces to Transform Customer Experiences
• Abcourt Mines Secures $5.25 Million Through Strategic Placement
• Exciting Developments in Aldoxorubicin Approval Pathway
• Investigation Announced for Five9, Inc. Amid Investor Concerns
• Massachusetts Bay Authority Receives AA+ Rating on Bonds
• Alter Domus Expands Global Presence with Manila Office Opening
• Kyverna Therapeutics, Inc. Under Investigation: What Investors Should Know
• Halmont Properties Corporation Enhances Transparency in MD&A
• Financial Institutions, Inc. Announces Strategic Stock Offering
• W&T Offshore Takes Legal Action Against Insurance Companies
• NICE Recovery Systems and Team Telenor Join Forces for Success
• Metagenomi Showcases Advanced Genome Editing Tools for Patients
• OCLC's Recognition as a Top Workplace in IT for 2025
• Revolutionizing Edge AI: E2IP Launches New Sensing Platform
• Join the Movement: Investors Claim Against Hasbro, Inc.
• Unveiling E2IP's Advanced Edge AI Sensing Platform Today
• NorthView Acquisition Corporation Addresses Nasdaq Compliance Issue
• DNP's Breakthrough in EUV Photomask Technology for Semiconductors
• Projected Growth of Cosmeceutical Market Through 2031
• Sintana Energy Advances in Exploration Activities in Namibia
• Insights from Capital Clean Energy Carriers Corp. Webinar
• Investigation of Applied Therapeutics: Investors Take Action
• Racing Optics' Innovative Twilight Tearoff Revolutionizes Safety
• Equitable Bank Lowers Lending Rate for Increased Accessibility
• Itron Celebrates Major Triumph with 50 Temetra Installations
• Ormat Technologies Launches Secondary Stock Offering
• College Housing Northwest Launches Abigail Court for Students
• Datalogz Innovates BI Governance with New BI Ops Approach
• Marqeta Faces Class Action Lawsuit: Investors Urged to Act
• Transforming Learning: The Future of Professional Development
• Heparin Market Expected to Expand by $3.34 Billion by 2028
• Insights on the Growth of the Dry Bulk Shipping Market
• Exploring Canoe EIT Income Fund's 2024 Redemption Details
• Credit Ratings Assigned to Atlanta Life Insurance Company
• Unlocking Data's Potential: Datalogz's Insights from Fireside Chat
• Exploring the Surge of InsurTech: The Future is Here
• Significant Developments in Intellectual Property Legal Battle